Open Access 01-12-2018 | Commentary
The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors
Published in: Cardiovascular Diabetology | Issue 1/2018
Login to get access